NCT00624858 - A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Depression

Interventions

DRUG

naltrexone SR 32 mg/ bupropion SR 360 mg daily

"All subjects are to complete a 4 week titration period at which time subjects will be titrated up to a maintenance level of study drug. Subjects will then take the maintenance dose of study drug for an additional 20 weeks.~During the study, subjects will receive ancillary therapy including advice on diet and exercise"

Trial Locations (1)

45040

Lindner Center of HOPE, Mason